Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir

AIM: To examine the efficacy of telbivudine (LdT) + adefovir (ADV) vs continuation of lamivudine (LAM) + ADV in patients with LAM-resistant chronic hepatitis B (CHB) who show a suboptimal response to LAM + ADV. METHODS: This was a randomized, active-control, open-label, single-center, parallel trial...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Park, Hana, Park, Jun Yong, Kim, Seung Up, Kim, Do Young, Han, Kwang-Hyub, Chon, Chae Yoon, Ahn, Sang Hoon
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837266/
https://ncbi.nlm.nih.gov/pubmed/24431895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i43.7671
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars